Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic lithium intake and hyperparathyroidism.

A Prasad

    European Journal of Clinical Pharmacology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Long-term lithium therapy can lead to hyperparathyroidism, a condition affecting calcium levels. This complication may coincide with worsening depressive symptoms in patients previously stable on lithium treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Post-traumatic Patellar Tendon Repair with Ipsilateral Peroneus Tendon Augmentation Post Total Knee Arthroplasty: A Case Report.

    Malaysian orthopaedic journal·2026
    Same author

    The impact of intra-abdominal pressure on urine output in postoperative cardiac surgery patients: Insights from continuous monitoring.

    Journal of critical care·2025
    Same author

    The Surface-Topography Challenge: A Multi-Laboratory Benchmark Study to Advance the Characterization of Topography.

    Tribology letters·2025
    Same author

    Interrelationships between social exclusion, mental health and wellbeing in adolescents: insights from a national <i>Youth Survey</i>.

    Epidemiology and psychiatric sciences·2025
    Same author

    Amphibian Segmentation Clock Models Suggest How Large Genome and Cell Sizes Slow Developmental Rate.

    Integrative organismal biology (Oxford, England)·2024
    Same author

    On the design of low modulus Ti-Nb-Au alloys for biomedical applications.

    Journal of the mechanical behavior of biomedical materials·2024
    Same journal

    Efficacy and safety of Ensitrelvir in COVID-19 patients: a systematic review and meta-analysis with focus on viral clearance and RNA change.

    European journal of clinical pharmacology·2026
    Same journal

    Comparing National Health Technology Assessment approaches and the new European Joint Clinical Assessment framework: The case of onco-hematological medicines.

    European journal of clinical pharmacology·2026
    Same journal

    The efficacy of letrozole in the medical management of ectopic pregnancy: a systematic review and meta-analysis.

    European journal of clinical pharmacology·2026
    Same journal

    Detection of intravenous drug physicochemical incompatibilities in clinical practice: e-Harvis compared to reference tools.

    European journal of clinical pharmacology·2026
    Same journal

    Efficacy and safety of doravirine/islatravir for the treatment of HIV-1: a systematic review and meta-analysis of randomized controlled trials with GRADE assessment.

    European journal of clinical pharmacology·2026
    Same journal

    Critical analysis of digitalis glycosides: declining use but increasing poison-center exposure cases for digitoxin.

    European journal of clinical pharmacology·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Psychiatry
    • Pharmacology

    Background:

    • Lithium is a widely used mood stabilizer for bipolar disorder.
    • Long-term lithium use is associated with various endocrine side effects.
    • Hyperparathyroidism is a condition characterized by overactive parathyroid glands.

    Observation:

    • Two patients on long-term lithium therapy presented with hyperparathyroidism.
    • The development of hyperparathyroidism coincided with a relapse of severe depressive symptoms.
    • These depressive symptoms had been previously well-controlled with lithium.

    Findings:

    • Lithium therapy may precipitate or exacerbate hyperparathyroidism.
    • Hyperparathyroidism could be a contributing factor to the recurrence of severe depressive symptoms.

    Related Experiment Videos

  • The interplay between lithium, parathyroid function, and mood regulation warrants further investigation.

    • Implications:

    • Clinicians should monitor parathyroid function in patients on long-term lithium.
    • Investigating hyperparathyroidism may be crucial in managing lithium-treated patients with mood symptom recurrence.
    • This highlights the importance of comprehensive endocrine monitoring during psychiatric pharmacotherapy.